Steven Cohen's CORT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 56,181 shares of Corcept Therapeutics Incorporated (CORT) worth $2.26 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CORT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 56,181 shares. Largest reduction occurred in Q2 2023, reducing 1,884 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Corcept Therapeutics Incorporated (CORT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Corcept Therapeutics Incorporated (CORT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +56,181 | New Buy | 56,181 | $40.31 |
| Q4 2023 | -1,690 | Sold Out | 0 | $0.00 |
| Q3 2023 | +1,025 | Add 154.14% | 1,690 | $27.25 |
| Q2 2023 | -1,884 | Reduce 73.91% | 665 | $22.25 |
| Q1 2023 | +2,549 | New Buy | 2,549 | $21.66 |
Steven Cohen's Corcept Therapeutics Incorporated Investment FAQs
Steven Cohen first purchased Corcept Therapeutics Incorporated (CORT) in Q1 2023, acquiring 2,549 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Corcept Therapeutics Incorporated (CORT) for 5 quarters since Q1 2023.
Steven Cohen's largest addition to Corcept Therapeutics Incorporated (CORT) was in Q1 2026, adding 56,181 shares worth $2.26 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 56,181 shares of Corcept Therapeutics Incorporated (CORT), valued at approximately $2.26 M.
As of the Q1 2026 filing, Corcept Therapeutics Incorporated (CORT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Corcept Therapeutics Incorporated (CORT) was 56,181 shares, as reported at the end of Q1 2026.